ArticleThe Australasian journal of dermatology2022
Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'.
Pascale Guitera, Andreanne Waddell, Elizabeth Paton, Gerald B Fogarty, Angela Hong, Richard A Scolyer, Jonathan R Stretch, Brett A O'Donnell, Giovanni Pellacani
Open access · hybridAbstract readLetterComment
In one paragraphArticle in The Australasian journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors at 7 institutions in 4 countries.
Pascale GuiteraMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Andreanne WaddellDepartment of Medicine/Division of Dermatology, Universite de Sherbrooke, Sherbrooke, Quebec, Canada.
Elizabeth PatonMelanoma and Skin Cancer Trials (MASC Trials), Monash University, Melbourne, Australia.
Gerald B FogartyMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Angela HongMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Jonathan R StretchMelanoma Institute Australia, The University of Sydney, Sydney, Australia.
Brett A O'DonnellDepartments of Ophthalmology, Royal North Shore Hospital, Sydney, Australia.
Giovanni PellacaniDepartment of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.
Genesis HealthCare · USUniversity of Sydney · AUCancer Trials Australia · AUMelanoma Institute Australia · AURoyal North Shore Hospital · AUUniversité de Sherbrooke · CAUniversity of Modena and Reggio Emilia · IT
Funding
Cancer Australia Priority-driven Collaborative Cancer Research Scheme 1083221Council of Australian University LibrariansRoyal Australian and New Zealand College of Radiologists 2014/RANZCR/005
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic AgentsHutchinson's Melanotic FreckleSkin NeoplasmsAminoquinolinesHumansImiquimodAminoquinolinesAntineoplastic AgentsImiquimoddiagnosisHutchinson's Melanotic FreckleImiquimodLentigo malignaMultidisciplinary consensuspathologytreatment.
Identifiers
PMID35107826
PMCPMC9305957
OpenAlexW4210419208
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390